NCT00003484View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

November 30, 2003

Study Completion Date

March 31, 2010

Conditions
Brain and Central Nervous System TumorsNeuroblastoma
Interventions
DRUG

carmustine

DRUG

irinotecan hydrochloride

PROCEDURE

surgical procedure

RADIATION

iodine I 131 monoclonal antibody 81C6

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Darell D. Bigner, MD, PhD

OTHER

NCT00003484 - Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors | Biotech Hunter | Biotech Hunter